233 related articles for article (PubMed ID: 34855908)
1. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.
Nagai J; Ishikawa Y
PLoS One; 2021; 16(12):e0260980. PubMed ID: 34855908
[TBL] [Abstract][Full Text] [Related]
2. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.
Nomura K; Takahashi K; Hinomura Y; Kawaguchi G; Matsushita Y; Marui H; Anzai T; Hashiguchi M; Mochizuki M
Drug Des Devel Ther; 2015; 9():3031-41. PubMed ID: 26109846
[TBL] [Abstract][Full Text] [Related]
3. Association of non-steroidal anti-inflammatory drug use with encephalopathy development: An analysis using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) databases.
Kawada K; Ishida T; Yoshioka T; Fukuda H; Hayashi T; Goda M; Ishizawa K
Pharmazie; 2024 Jun; 79(6):118-123. PubMed ID: 38877682
[TBL] [Abstract][Full Text] [Related]
4. Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database.
Yin G; Song G; Xue S; Liu F
Sci Rep; 2024 May; 14(1):11367. PubMed ID: 38762547
[TBL] [Abstract][Full Text] [Related]
5. Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System.
Battini V; Carnovale C; Clementi E; Sessa M
Expert Opin Drug Saf; 2023; 22(11):1105-1112. PubMed ID: 37293948
[TBL] [Abstract][Full Text] [Related]
6. Signal mining and analysis for central nervous system adverse events due to taking oxycodone based on FAERS database.
Wu X; Zhang L; Huang H; Huang L; Lu X; Wang Z; Xiao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):422-434. PubMed ID: 37164926
[TBL] [Abstract][Full Text] [Related]
7. Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database.
Zhang S; Wang Y; Qi Z; Tong S; Zhu D
Int J Clin Pharm; 2024 Apr; 46(2):471-479. PubMed ID: 38245664
[TBL] [Abstract][Full Text] [Related]
8. Exploration of adverse events associated with risdiplam use: Retrospective cases from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Yu L; Liu L
PLoS One; 2024; 19(3):e0298609. PubMed ID: 38427665
[TBL] [Abstract][Full Text] [Related]
9. Cardiac toxicity of brentuximab vedotin: a real-word disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database.
Ke C; Chen M; Huang Y; Chen Y; Lin C; Huang P
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5253-5264. PubMed ID: 38270617
[TBL] [Abstract][Full Text] [Related]
10. Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database.
Wang Q; Qu K; Du Z; Shen Y; Jiang Y; Zhu H
J Psychopharmacol; 2024 Jun; 38(6):562-566. PubMed ID: 38641957
[TBL] [Abstract][Full Text] [Related]
11. Real-world safety of Levetiracetam: Mining and analysis of its adverse drug reactions based on FAERS database.
He Z; Liu C; Lin L; Feng G; Wu G
Seizure; 2024 Apr; 117():253-260. PubMed ID: 38537425
[TBL] [Abstract][Full Text] [Related]
12. Data mining techniques for detecting signals of adverse drug reaction of cardiac therapy drugs based on Jinan adverse event reporting system database: a retrospective study.
Guan Y; Qi Y; Zheng L; Yang J; Zhang M; Zhang Q; Ji L
BMJ Open; 2023 Jan; 13(1):e068127. PubMed ID: 36669842
[TBL] [Abstract][Full Text] [Related]
13. Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system.
Zhang W; Chen M; Cai X; Zhang M; Hu M; Hu Y; Yang Y; Zhu J; Du Y; Yang C
Expert Opin Drug Saf; 2024 May; 23(5):617-625. PubMed ID: 38568141
[TBL] [Abstract][Full Text] [Related]
14. Strong opioids-induced cardiac, neurologic, and respiratory disorders: a real-world study from 2004 to 2023 based on FAERS.
Dai M; Dou X; Chen M; Yang J; Long J; Lin Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4105-4121. PubMed ID: 38032491
[TBL] [Abstract][Full Text] [Related]
15. Adverse events with pemigatinib in the real world: a pharmacovigilance study based on the FDA Adverse Event Reporting System.
Zhao D; Long X; Wang J
Expert Opin Drug Saf; 2024 May; 23(5):599-605. PubMed ID: 38553867
[TBL] [Abstract][Full Text] [Related]
16. A Real-World Disproportionality Analysis of Drug-Induced Immune Hemolytic Anemia in the FDA Adverse Event Reporting System.
Tang L; Ding C; Li H; Zhou X; Yin G
Ann Pharmacother; 2024 Apr; 58(4):375-382. PubMed ID: 37522435
[TBL] [Abstract][Full Text] [Related]
17. A pharmacovigilance study of adverse event profiles and haemorrhagic safety of bevacizumab based on the FAERS database.
Tang L; Ding C; Li H; Yin G; Zhang H; Liu WS; Ji Y; Li H
Expert Opin Drug Saf; 2024 Feb; 23(2):213-220. PubMed ID: 37581403
[TBL] [Abstract][Full Text] [Related]
18. Rising cases of drug-induced pulmonary fibrosis: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database, 2000-2022.
McCall KL; Hennig KR; Abe ZT; Dattler DN; Hurd KL; Portnoy SL; Zagoria ZJ
Pharmacoepidemiol Drug Saf; 2024 May; 33(5):e5797. PubMed ID: 38680101
[TBL] [Abstract][Full Text] [Related]
19. Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System.
Zhao D; Long X; Zhou J; Wang J
Drugs R D; 2023 Dec; 23(4):403-409. PubMed ID: 37700091
[TBL] [Abstract][Full Text] [Related]
20. A real-world data analysis of acetylsalicylic acid in FDA Adverse Event Reporting System (FAERS) database.
Zhao B; Zhang X; Chen M; Wang Y
Expert Opin Drug Metab Toxicol; 2023; 19(6):381-387. PubMed ID: 37421631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
